See analyst estimates and all valuation multiples for Chemicals
Company | EV | EV/Revenue | EV/EBITDA |
---|---|---|---|
$232B | 7.0x | 17.8x | |
$101B | 4.3x | 22.1x | |
$78.8B | 5.0x | 21.6x | |
$75.2B | 6.3x | 14.9x | |
$66.4B | 0.9x | 7.5x | |
$47.4B | 2.7x | 7.0x | |
$46.5B | 1.2x | 8.9x | |
$45.9B | 3.2x | 16.6x | |
$45.0B | 21.3x | 469.2x | |
$40.9B | 1.6x | 7.4x | |
$37.3B | 1.4x | 8.4x | |
$37.3B | 0.9x | 7.5x | |
$33.5B | 1.0x | 9.5x | |
$33.4B | 2.7x | 10.4x | |
$32.8B | 7.4x | 20.0x | |
$31.1B | 2.1x | 12.5x | |
$30.8B | 2.0x | 10.7x | |
$29.1B | 0.8x | 7.3x | |
$28.1B | 2.5x | 13.0x | |
$25.5B | 6.4x | 35.7x | |
$24.8B | 0.7x | 5.7x | |
$23.3B | 3.9x | 9.8x | |
$20.2B | 3.7x | 10.8x | |
$19.8B | 2.2x | 9.6x | |
$19.7B | 1.7x | 10.8x | |
$18.4B | 3.2x | 15.5x | |
$18.0B | 0.5x | 2.2x | |
$17.8B | 1.8x | 8.0x | |
$17.6B | 4.1x | 15.9x | |
$16.3B | 2.2x | 14.4x | |
$15.9B | 6.4x | 22.1x | |
$15.8B | 1.3x | 9.4x | |
$15.5B | 1.0x | 12.6x | |
$15.5B | 3.1x | 11.2x | |
$15.2B | 2.5x | 6.6x | |
$14.1B | 0.8x | 6.0x | |
$13.6B | 1.4x | 7.6x | |
$13.3B | 1.1x | 6.3x | |
$12.8B | 0.7x | 7.6x | |
$12.6B | 2.7x | 8.2x | |
$12.2B | 0.8x | 5.5x | |
$11.2B | 2.1x | 10.3x | |
$10.1B | 1.4x | 5.8x | |
$9.8B | 4.5x | 10.6x | |
$9.4B | 3.2x | 8.6x | |
$9.3B | 1.7x | 14.0x | |
$9.0B | 1.2x | 5.7x | |
$8.7B | 0.8x | 5.1x | |
$8.3B | 2.0x | 9.2x | |
$7.1B | 0.5x | 2.7x | |
$6.4B | 3.0x | 9.1x | |
$6.1B | 2.4x | -896.4x | |
$6.0B | 6.3x | 23.0x | |
$5.7B | 1.4x | 9.4x | |
$5.5B | 1.2x | 9.5x | |
$5.4B | 1.1x | 6.6x | |
$5.3B | 0.7x | 7.7x | |
$5.2B | 0.6x | 7.2x | |
$5.0B | 0.9x | 4.3x | |
$4.7B | 2.5x | 10.1x | |
$4.5B | 1.7x | 13.4x | |
$4.4B | 5.8x | 19.8x | |
$4.4B | 0.7x | 5.2x | |
$4.1B | 0.4x | 13.4x | |
$4.0B | n/a | n/a | |
$3.7B | 1.7x | 8.0x | |
$3.5B | 1.1x | 5.4x | |
$3.4B | 12.4x | 47.2x | |
$3.3B | n/a | n/a | |
$3.3B | 0.8x | 15.3x | |
$3.3B | 7.1x | 23.0x | |
$3.2B | 5.2x | 29.5x | |
$3.0B | 0.7x | 4.7x | |
$2.8B | 0.8x | -69.4x | |
$2.4B | n/a | n/a | |
$2.0B | 2.2x | 11.6x | |
$2.0B | 0.6x | 5.2x | |
$2.0B | 2.7x | 10.4x | |
$1.9B | 0.7x | 5.6x | |
$1.8B | 0.2x | 5.7x | |
$1.7B | 1.5x | 11.2x | |
$1.7B | 6.8x | 20.7x | |
$1.4B | 2.3x | 11.9x | |
$1.4B | 1.5x | 8.4x | |
$1.3B | 2.5x | n/a | |
$1.3B | 1.3x | 12.3x | |
$1.3B | n/a | n/a | |
$1.2B | 1.5x | 6.7x | |
$978M | 2.4x | 34.6x | |
$972M | 0.6x | 5.9x | |
$875M | 0.5x | 13.0x | |
$723M | n/a | n/a | |
$664M | 0.6x | 4.6x | |
$637M | 1.1x | 8.2x | |
$616M | 1.4x | 6.8x | |
$581M | 0.5x | n/a | |
$568M | n/a | n/a | |
$539M | 1.4x | 9.4x | |
$519M | 1.0x | 6.2x | |
$513M | 0.2x | 16.5x | |
$465M | 1.9x | 12.4x | |
$425M | 9.0x | 29.3x | |
$408M | 0.3x | 4.3x | |
$390M | 0.6x | 5.4x | |
$348M | 1.6x | 9.0x | |
$325M | 0.6x | 4.5x | |
$317M | 0.6x | 7.1x | |
$313M | n/a | n/a | |
$313M | 0.2x | 2.9x | |
$313M | 0.6x | 2.1x | |
$279M | 0.6x | 6.0x | |
$260M | n/a | n/a | |
$246M | 6.8x | -7.3x | |
$227M | n/a | n/a | |
$204M | n/a | n/a | |
$169M | n/a | n/a | |
$165M | 322.4x | -339.9x | |
$159M | 2.4x | -3.9x | |
$152M | 0.3x | 4.0x | |
$150M | 0.6x | 3.9x | |
$140M | 10.3x | -4.9x | |
$134M | n/a | n/a | |
$134M | 1.2x | 6.5x | |
$117M | 5.9x | 17.9x | |
$101M | n/a | n/a | |
$100M | n/a | n/a | |
$88.0M | n/a | n/a | |
$83.1M | 583.8x | -14.3x | |
$69.7M | n/a | n/a | |
$69.3M | 0.6x | 9.6x | |
$68.6M | 32.9x | -2.0x | |
$64.8M | 0.7x | 3.7x | |
$59.4M | n/a | n/a | |
$47.1M | 0.6x | 4.7x | |
$41.9M | n/a | n/a | |
$40.0M | n/a | n/a | |
$38.7M | 2.3x | 14.5x | |
$38.4M | n/a | n/a | |
$34.5M | n/a | n/a | |
$34.3M | 0.5x | -49.3x | |
$32.4M | n/a | n/a | |
$31.2M | 0.4x | 8.4x | |
$30.1M | 1.4x | 27.4x | |
$26.6M | n/a | n/a | |
$26.3M | 2.0x | 36.6x | |
$25.7M | n/a | n/a | |
$25.3M | n/a | n/a | |
$25.0M | n/a | n/a | |
$23.1M | 50.2x | -1.9x | |
$20.4M | 2.0x | -9.9x | |
$20.1M | n/a | n/a | |
$19.8M | n/a | n/a | |
$16.1M | n/a | n/a | |
$15.8M | 4.1x | -2.4x | |
$15.0M | 2.5x | -1261.7x | |
$13.6M | n/a | n/a | |
$12.4M | n/a | n/a | |
$12.4M | 1.3x | -4.0x | |
$9.9M | n/a | n/a | |
$7.4M | 26.1x | -11.0x | |
$7.1M | n/a | n/a | |
$6.8M | n/a | n/a | |
$6.2M | n/a | n/a | |
$6.1M | n/a | n/a | |
$5.5M | n/a | n/a | |
$4.3M | n/a | n/a | |
$4.1M | n/a | n/a | |
$4.0M | n/a | n/a | |
$3.4M | n/a | n/a | |
$3.3M | n/a | n/a | |
$1.5M | n/a | n/a | |
$1.4M | n/a | n/a | |
$1.3M | n/a | n/a | |
$1.1M | n/a | n/a | |
$0.9M | n/a | n/a | |
$0.8M | n/a | n/a | |
$0.2M | n/a | n/a | |
-$1.6M | -15.0x | 0.4x |
Valuation multiples as of last 12 months (LTM). Financial data powered by Morningstar, Inc.
See analyst estimates and M&A multiples for Chemicals